TBB

CAS No. 17374-26-4

TBB ( NSC 231634; Tetrabromobenzotriazole )

Catalog No. M12636 CAS No. 17374-26-4

TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 49 In Stock
25MG 77 In Stock
50MG 124 In Stock
100MG 188 In Stock
200MG 293 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TBB
  • Note
    Research use only, not for human use.
  • Brief Description
    TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).
  • Description
    TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).
  • Synonyms
    NSC 231634; Tetrabromobenzotriazole
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CK2; CDK2; GSK-3β
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    17374-26-4
  • Formula Weight
    434.71
  • Molecular Formula
    C6HBr4N3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO, Ethanol: 100 mM
  • SMILES
    BrC1=C(NN=N2)C2=C(Br)C(Br)=C1Br
  • Chemical Name
    4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Orzechowska E, et al. Oncol Rep. 2012 Jan;27(1):281-5.
molnova catalog
related products
  • Ocaperidona

    Ocaperidona (Ocaperidone), a very high affinity dopamine D2antagonist.

  • IIIM-290

    IIIM-290 is a potent, orally active cyclin-dependent kinase (CDK) inhiitor with IC50 of 1.9 and 16 nM for Cdk-9/T1 and Cdk-2/A, respectively.

  • Ro-3306

    Ro-3306 is a potent and selective inhibitor of CDK1, with Kis of 20 nM, 35 nM and 340 nM for CDK1, CDK1/cyclin B1 and CDK2/cyclin E, respectively.